s the multidrug-resistant TB (MDR-TB) remains a significant public health crisis with only a fraction of affected individuals accessing treatment globally, the World Health Organization (WHO) has recommended adoption of targeted next-generation sequencing (tNGS) tests for diagnosing drug-resistant